Strategically located 343,000 sq ft Cambridge Discovery Campus given go ahead by planners
Resolution to grant permission for new science and innovation campus to the south of Cambridge city.
Biotech start-up BugBiome secures investment for pioneering research in sustainable pest protection
BugBiome raises £310k in pre-seed investment from Cambridge Angels and Discovery Park Ventures Investment enables a £330k Engineering Biology Grant from Innovate UK for cutting-edge agri-tech research leveraging the microbiome and engineering biology approaches.Cambri
Creative Places enters new era with the appointment of new partner and the retirement of co-founder
Seb Denby is promoted to Partner as co-founder Jonathan Burroughs retires.
FutureIN wins Apprenticeship Initiative of the Year at Construction News Workforce Awards 2023
Local initiative transforming the lives of young people in need gains national award.
Maxion Therapeutics expands team and facilities with move to Unity Campus
Maxion takes 7,644 sq ft Suite 4 in The Works, Unity Campus
Cambourne Park Science & Technology Campus unveils new identity and welcomes first letting under new ownership
Life Science REIT, owners of Cambourne Park Science & Technology Campus (formerly Cambourne Business Park), is delighted to welcome Rakon to the Campus, in addition to launching its re-positioning of the Campus to the market.
Isomerase secures first pre-let within the Newnham Building at Chesterford Research Park
Chesterford Research Park is delighted to confirm that Isomerase will take up occupancy within Suite 4 of the Newnham Building upon its completion in mid 2020. The move will facilitate planned future growth for the successful nature products discovery and development provider.
Isogenica announces new licence agreement with Takeda
Isogenica Ltd, a leader in the design and construction of innovative and highly diverse synthetic antibody libraries, today announced a new licensing deal with Takeda Pharmaceutical Company Limited (TSE: 4502), a global research and development-driven pharmaceutical company focused on oncology, gastroenterology and central nervous system disorders.
RPC Consulting expands at Chesterford Research Park
Insurance sector specialists RPC Consulting take on further space within the Mansion House to support growing actuarial software team.
Leading R&D property advisor, Creative Places, shortlisted for prestigious national award
Cambridge-based Creative Places is one of six finalists for Estate Gazettes Specialist Advisor of the Year 2016 award.
Antarctica – earth’s coldest, driest and windiest continent beckons for successful four
The United Kingdom Antarctic Heritage Trust’s search for a team of four to spend five months at Port Lockroy on the Antarctic Peninsula, culminated in a rigorous two day selection programme.
RJW & partners strengthen senior level expertise with appointment of Muneer Ahmad
Muneer Ahmad joins pricing and market access consultants to the pharmaceutical and medical device industries, RJW & partners.
Commercial R&D property advisor, Creative Places, launches new brand identity
Step-change in the visual identity creates a look and feel commensurate with Creative Places’ innovative, strategic approach and reflects the company's evolution to date.
Oncologica’s success within the personalised medicine’s arena drives expansion at Chesterford
The Diagnostic Services and Contract Research Organisation take a further suite within The Science Village, Chesterford’s high quality, prestigious self-contained accommodation.
Anglia Capital Group target region's rapid growth sectors with move to Norwich Research Park
Centrum, Norwich Research Park's research, innovation and business hub is the ideal location for the new private investor network, giving the company direct access to the movers and shakers at the Park and beyond.